The Indonesian government has preordered 50 million doses of a potential COVID-19 vaccine from Chinese pharma giant Sinovac Biotech. The potential vaccine will be delivered in the form of vaccine bulks and is scheduled to arrive gradually, starting in November.
State-owned pharmaceutical company Bio Farma will examine and modify the potential vaccine as needed while waiting for completion of phase 3 of the clinical trial. If all goes well, the government plans to begin a COVID-19 vaccination program in early 2021. For this project, the government has allocated Rp 37 trillion (US$2.5 billion), with Rp 3.3 trillion disbursed this year for the down payment for the order.
The question is whether the vaccine procurement program is a proper strategy to handle the COVID-19 pandemic.
There is still no specific and permanent treatment for COVID-19. Although healt…